BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19269848)

  • 1. Identifying tumor antigens in endocrine malignancies.
    Wuttke M; Papewalis C; Jacobs B; Schott M
    Trends Endocrinol Metab; 2009 Apr; 20(3):122-9. PubMed ID: 19269848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New concepts in tumor antigens: their significance in future immunotherapies for tumors.
    Yang F; Yang XF
    Cell Mol Immunol; 2005 Oct; 2(5):331-41. PubMed ID: 16368059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
    Weide B; Garbe C; Rammensee HG; Pascolo S
    Immunol Lett; 2008 Jan; 115(1):33-42. PubMed ID: 18006079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of tumor immunity, immunotherapy and cancer vaccines.
    Ostrand-Rosenberg S
    Curr Opin Immunol; 2004 Apr; 16(2):143-50. PubMed ID: 15023405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies.
    Sbiera S; Wortmann S; Fassnacht M
    Horm Metab Res; 2008 Feb; 40(2):89-98. PubMed ID: 18283626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer.
    Gross S; Walden P
    Immunol Lett; 2008 Feb; 116(1):7-14. PubMed ID: 18164076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer.
    Egloff AM; Vella LA; Finn OJ
    Cancer Res; 2006 Jan; 66(1):6-9. PubMed ID: 16397206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells in autoimmune endocrine diseases.
    Wong FS; Dayan CM
    Trends Endocrinol Metab; 2008 Oct; 19(8):292-9. PubMed ID: 18786834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigens for cancer immunotherapy.
    Neller MA; López JA; Schmidt CW
    Semin Immunol; 2008 Oct; 20(5):286-95. PubMed ID: 18951039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses.
    de Souza AP; Bonorino C
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1317-32. PubMed ID: 19761435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular therapies in endocrine diseases.
    Papewalis C; Jacobs B; Wuttke M; Schott M
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S33-9. PubMed ID: 18777451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. About human tumor antigens to be used in immunotherapy.
    Lucas S; Coulie PG
    Semin Immunol; 2008 Oct; 20(5):301-7. PubMed ID: 18395462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New principles in tumor antigens and their significance in future immunotherapies for lymphomas and other malignancies--editorial].
    Ke XY; Wang J; Yang XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):419-26. PubMed ID: 16800912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-endocrine interactions in autoimmune thyroid diseases.
    Klecha AJ; Barreiro Arcos ML; Frick L; Genaro AM; Cremaschi G
    Neuroimmunomodulation; 2008; 15(1):68-75. PubMed ID: 18667802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.
    Chiriva-Internati M; Cobos E; Kast WM
    Int Rev Immunol; 2007; 26(3-4):197-222. PubMed ID: 17558744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated antigens and biomarkers in cancer and immune therapy.
    Malyankar UM
    Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.